systematic genetic interaction maps in microorganisms are powerful tools for identifying functional relationships between genes and for defining the function of uncharacterized genes. We have recently implemented this strategy in mammalian cells as a twostage approach. First, genes of interest are robustly identified in a pooled genome-wide screen using complex shrna libraries. second, phenotypes for all pairwise combinations of 'hit' genes are measured in a double-shrna screen and used to construct a genetic interaction map. our protocol allows for rapid pooled screening under various conditions without a requirement for robotics, in contrast to arrayed approaches. each round of screening can be implemented in ~2 weeks, with additional time for analysis and generation of reagents. We discuss considerations for screen design, and we present complete experimental procedures, as well as a full computational analysis suite for the identification of hits in pooled screens and generation of genetic interaction maps. although the protocol outlined here was developed for our original shrna-based approach, it can be applied more generally, including to crIspr-based approaches.
IntroDuctIon
The recent revolution in sequencing technology has facilitated the collection of massive amounts of human genomic sequence and expression data. To understand the function of the human genome and its role in disease, a complementary set of functional genomics tools is required. In particular, there is an acute need for methods that systematically discover pathway relationships between genes. One such method is the use of high-density genetic interaction maps, which report on pairwise measurements of the extent to which perturbing one gene's function impacts the function of a second gene. These maps have proven to be powerful tools in haploid microorganisms such as yeast for understanding coordinated gene function and for identifying novel roles for poorly characterized genes [1] [2] [3] [4] [5] [6] [7] [8] . Recently, we 9, 10 and others 11, 12 have described efforts to construct and analyze genetic interaction maps in mammalian cells. Here we describe a step-by-step protocol for conducting genetic screens and creating genetic interaction maps based on our approach 9, 10, 13 .
Our current technology platform uses RNAi to knock down genes. In the first stage, we define genes of interest in a pooled genome-wide screen, and in the second stage we systematically determine all genetic interactions between these genes (Fig. 1) . Although RNAi proved to be a transformative technology for the study of mammalian cells, genome-wide RNAi screens have been plagued by false-positive and false-negative results 14 . To address these issues, we designed an ultracomplex genome-wide shRNA library in which each protein-coding human gene is targeted by ~25 independent shRNAs. The library also contains thousands of matched negative controls. We have developed a quantitative framework for deriving shRNA phenotypes from pooled screens using such libraries, and for robustly detecting statistically significant hit genes whose knockdown results in a phenotype of interest 9 . To determine genetic interactions between hits from the primary screen, shRNAs targeting the hit genes are individually cloned, batch-validated and then used to construct a pooled double-shRNA library in a single ligation reaction. Double-shRNA phenotypes are determined in a pooled screen and used to construct a genetic interaction map.
Two other approaches for large-scale genetic interaction maps in mammalian cells were recently published by other groups 11, 12 . These alternative approaches are based on arrayed screening of combinations of siRNA or esiRNA reagents in separate wells. An advantage of arrayed approaches is the possibility to monitor complex phenotypes, such as cell morphology. However, specialized high-throughput equipment is required to implement them. Pooled screening strategies [15] [16] [17] [18] , including ours 9, 10 , have several important benefits, such as uniformity of growth conditions, and scalability, which is crucial to rapidly generate large genetic interaction maps and to compare genetic interaction maps across many different treatment conditions and genetic backgrounds. In addition, our strategy for creating libraries, quantitative framework and the computational pipeline for the analysis of pooled screens and the construction of genetic interaction maps 9, 10 apply more generally to other methodologies for interfering with gene expression, such as CRISPR-based modulation of gene transcription [19] [20] [21] [22] .
Applications of mammalian genetic interaction maps
We have demonstrated that a mammalian genetic interaction map can be used to identify new protein complexes and to identify novel roles for known complexes involved in the biology of the toxin ricin 10 . Other groups have shown that genetic interaction maps in mammalian cells can be used to gain insight into chromatin regulation 12 . We expect the potential uses of these maps to be very broad. The ability to query hundreds of thousands of gene pairs in parallel for synthetic lethality in the context of cancer models promises to accelerate the identification of combination drug targets. The comparison of genetic interaction maps obtained under different conditions or in cells with different genetic backgrounds can reveal the rewiring of pathways in normal and disease states.
The protocol described here was used to produce our published genetic interaction map for factors controlling susceptibility of the human K562 leukemia cell line to ricin 10 . We are currently optimizing several aspects of our methodology for use in future studies. These aspects include the design of next-generation shRNA libraries, the use of bioreactors for large-scale pooled screens and the streamlined preparation of samples for deep sequencing, in which we are aiming to replace the gel purification step with size selection using solid-phase reversible immobilization beads.
Limitations
Our strategy for primary screens has performed very well for screens comparing the growth of untreated cells with the growth of cells in the presence of a drug or toxin that causes an intermediate selective pressure. By contrast, treatments that kill more than 50% of the cell population at a given time should be avoided, and instead several rounds of moderate treatment should be used. In such screens, our method has successfully identified factors whose knockdown either sensitizes or protects cells from the treatment, as compared with wild-type (WT) cells.
The single most important factor in obtaining reliable data from pooled screens is the representation of library elements in the cell population. Although we aim for 1,000-4,000-fold representation, our pilot experiments have shown that higher representation results in even better signal-to-noise ratios 10 . A resulting limitation is that whole-genome screens using our methodology cannot easily be conducted in experimental systems where the scale of the pooled population is very limited-including screens in mouse xenograft models.
Our strategy using ultracomplex libraries can robustly detect genes with even weak effects on the phenotype of interest 10 . However, it is possible that some relevant genes are not detected because the shRNA library does not contain enough shRNAs that knock down the gene sufficiently to observe the phenotype of interest. Furthermore, shRNAs that potently knock down genes that are essential for cell viability can get lost from the cell population before the beginning of the screen. This concern could be addressed by using inducible vectors (e.g., ref. 23 ).
Finally, it is important to keep in mind that the typical selection protocol used in the primary screen (which often takes around 12-14 d) enables the detection of small differences in fitness or resistance to a selective pressure conferred by a given shRNA. This allows the identification of a wide range of genes of interest, which can then be characterized further in a systematic genetic interaction map. However, when validating hit genes individually, the observed effect in a short-term experiment (e.g., 2 d) may be comparatively small.
Experimental design
Pooled shRNA library. It is assumed that the experimenter begins with a pooled high-coverage shRNA library in the lentiviral plasmid pMK1047 (ref. 10) . Design and construction of such libraries has been described elsewhere 9, 10, 13 . For the purposes of screen design and analysis described here, essential features of these libraries are (i) ~10-25 shRNAs per gene, and (ii) large numbers (~500-1,000) of matched negative control shRNAs per sublibrary that are designed using the same rules as for the targeted shRNAs. The plasmids we are currently using for primary screens, batch retests of shRNAs and double-shRNA screens are annotated in Figure 2 . The vectors encode mCherry and puromycin, which allow monitoring of viral infection and selection for the presence of stably integrated virus.
Considerations for screen design. The protocol presented here applies to a screen based on growing cells under standard conditions or in the presence of selective pressure, such as the addition of a drug or toxin 10 . Quantification of the frequencies of cells expressing a specific shRNA in starting populations and in untreated and treated populations can be used to determine different shRNA phenotypes, which we have previously defined quantitatively 9 . In brief, gamma phenotypes quantify the effect of an shRNA on cell growth in the absence of treatment, tau phenotypes quantify the effect of an shRNA on cell growth in the presence of treatment and rho phenotypes quantify the effect of an shRNA on resistance to the treatment. Although growth and selection conditions must clearly be optimized for each screen and cell type, several general principles should guide screen design: Steps 47-58
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Steps 69-76 shRNA Pooled screen, deep sequencing
Step 77
Data analysis
Steps 78-95 Selection should be set up so that a sufficient dynamic range between treated and untreated conditions can be expected. In our screens, a difference of around six net doublings between treated and untreated conditions worked well to see major differences. With such a protocol, an shRNA conferring complete resistance to the selective pressure should be enriched 2 6 = 64-fold relative to a negative control shRNA. Given the complexity of the shRNA library, it is extremely important to avoid tight population bottlenecks at each stage of the experiment: lentiviral infection, screen selection and preparation of the sequencing sample. We aim to maintain 1,000-fold representation of each library shRNA on average at each stage. For example, for a screen of an shRNA library with 50,000 different shRNAs, the cell population should be maintained at 50 million cells or more. In particular, when designing a screen, care should be taken to avoid selective pressures that are so high that a large fraction of the cell population is killed. We aim for selective pressures that do not kill more than 50% of the population at any time point during the screen. Considerations for library representation also affect the numbers of double-shRNAs that can be queried for the construction of a genetic interaction map. For example, if the screen is carried out in a volume of 2 liters at a cell concentration of 500,000 cells per ml (i.e., a population of 1 billion cells), a representation of 1,000-fold would correspond to a complexity of 1 million, or all pairwise combinations of 1,000 different shRNAs. To get better
• quantitative data, we typically choose a representation of 4,000-fold for double-shRNA screens, which reduces the number of shRNAs in the above example to 500 × 500. We typically include 12 independent negative control shRNAs, which then form combinations with other negative control shRNAs (used to derive the WT phenotype in the screen) and combinations with genetargeting shRNAs (used to calculate single-gene phenotypes). Suspension cell lines facilitate culturing of large cell numbers, as they can easily be grown in large spinner flasks or bioreactors, and they do not require trypsinization for passaging but can simply be diluted. We had good experiences with the human K562 leukemia cell line, which does not grow in clusters and grows stably over many generations. Other suspension lines, including B cell, T cell and myeloma lines have also worked well in our hands. Adherent cell lines can be seeded on microcarriers and then grown in spinner flasks or bioreactors. We have successfully detected both positive and negative selection. However, it can be more challenging to confidently detect shRNAs that cause cells to drop out of the screen, especially if they also affect growth under standard conditions, as phenotypes for such shRNAs are then calculated on the basis of low numbers of reads in the sequencing data, which inherently will increase statistical noise.
Considerations for sample preparation. After the screen, genomic DNA is isolated from the different cell populations and the shRNA-encoding cassettes are PCR-amplified to generate a sample for deep sequencing. Our protocol was designed with the following goals: Adequate representation of the complex cell population should be maintained during library preparation. Genomic DNA is isolated from a number of cells that is 1,000-fold the number of different shRNAs in the screened library. To reduce the amount of genomic DNA used as a PCR template, we size-fractionate the DNA by a restriction enzyme digest (with PvuII); this is followed by gel purification of the size range around the expected fragment size of the shRNA expression cassette. We are currently testing an alternative approach based on DNA size selection with solid-phase reversible immobilization beads, which may be implemented in future versions of this protocol. During sample preparation from the primary screen, the DNA region encoding the shRNA is PCR-amplified. We found that amplification of this region creates bias against GC-rich shRNAs, presumably because the DNA is more likely to form secondary structures that interfere with amplification. Therefore, it is important that the exact same PCR protocol is used to amplify samples that will be compared during data analysis. Future versions of our library will implement a restriction site in the shRNA loop-encoding region to enable linker ligation followed by half-mer amplification, thus circumventing amplification of • • the full shRNA-encoding region. Other groups have previously developed analogous strategies 16, 24 .
In the PCR-amplified material, the shRNA-encoding region is highly enriched compared with its abundance in pre-PCR genomic DNA. Therefore, it is critical to avoid crosscontamination of pre-PCR material with any post-PCR material. Ideally, the pre-PCR steps should be performed using separate equipment (e.g., pipettes and vacuum manifolds) from that used for post-PCR steps.
Controls.
For pilot experiments, it is helpful to use positive and negative control shRNAs to assess the dynamic range of screening conditions. Cells infected with control lentivirus expressing mCherry can be mixed with WT cells and used to track changes in populations under mock selection conditions 10 .
To distinguish the effect that shRNAs have on cell growth under standard (untreated) conditions from treatment-specific effects, experiments should be designed to compare the population at the time point before selection (t0), the treated population at the endpoint of the experiment and a control untreated population that grew for the same time in parallel.
After infection of cells with the lentiviral library, vials of cells representing the library diversity at ~1,000-fold should be frozen to be used as t0 controls, backup vials and replicate experiments.
•
MaterIals

REAGENTS
Genome-wide shRNA library (e.g., in plasmid pMK1047, as described in refs. 9,10. Plasmid pMK1047 will be provided on request; 
• 1 month. Polybrene, 4 mg/ml Add 40 mg of polybrene to 10 ml of Millipore water and filter it through a 0.2-µm filter; freeze it in aliquots at −80 °C and store the aliquots indefinitely. Freezing medium Prepare freezing medium by adding 5 ml of DMSO to heat-inactivated FBS (10% (vol/vol) DMSO final); filter it through a 0.2-µm filter. Store the medium at −20 °C for up to 1 year. TAE buffer, 1× Prepare 1 liter of 1× TAE by combining 4.84 g of Tris base, 1.14 ml of acetic acid and 2 ml of 0.5 M EDTA (pH 8.0); adjust the volume to 1 liter with Milli-Q water (40 mM Tris, 20 mM acetic acid, 1 mM EDTA, pH 8.0 final). Store the buffer at room temperature (15-25 °C) for up to 6 months. EQUIPMENT SETUP Glass spreading rod In the flame of a Bunsen burner, heat the region of a glass Pasteur pipette ~5 cm below the tip. After a few seconds, the pipette will bend in the heated region; remove it from the flame. Now heat the very tip of the pipette to bend it toward the thick stem of the pipette. The resulting glass spreading rod allows scraping of colonies from agar plates without scratching the agar surface.
Creating an shRNA library fasta file Each entry describes one shRNA. Each shRNA name should begin with the Entrez Gene ID, followed by a double underscore and a number (or other information) that uniquely identifies the shRNA, e.g., 9064__NM_004672.3__24. Names of negative control shRNAs should have a 0 instead of an Entrez Gene ID, e.g., 0__0__1. The nucleotide sequence included for each shRNA is the reverse complement of the shRNA guide strand for the shRNA in your shRNA library. (The length of each sequence should be 22 nt, so if your guide strand is shorter include the reverse-complement sequence of the constant nucleotides following the guide strand in your shRNA construct.) To create a Bowtie index from this file, use the bowtie-build command. For example, if the path to bowtie-build on your computer is /Applications/bowtie-0.12.3/bowtie-build and the name of the fasta file for your shRNA library is LibraryName.fa, enter the following on the command line: /Applications/bowtie-0.12.3/bowtie-build LibraryName.fa LibraryName Six output files are created; move them to the subdirectory indices/. In the script 'align_primary.py' (subdirectory 'scripts'), specify the path to Bowtie on your computer in line 4. proceDure lentivirus preparation and infection • tIMInG 7-10 d ! cautIon All lentivirus work should be performed in Biosafety Level 2 containment; wear appropriate protective clothing, and dispose of lentivirus-infected materials using bleach.
1|
Trypsinize healthy, logarithmically dividing 293T cells and plate 7.5 × 10 6 cells in a 15-cm plate in 30 ml of 293T growth medium. Steps 1-5 describe the handling of one 15-cm plate, which is an appropriate scale for an shRNA library with a complexity of up to ~20,000. Scale up the number of plates for larger shRNA libraries as necessary.
2| 24 h after plating the cells, prepare the transfection mix at room temperature: add 48 µl of Mirus LT1 to 1,300 µl of DMEM (no additives), mix it and wait for 5 min. Add a mixture of 8 µg of pooled shRNA library (e.g., in plasmid backbone pMK1047) and 8 µg of an equal mix of packaging plasmids (pMDL, pRSV and pVSVG). Mix, wait for 20 min at room temperature and then add the mixture dropwise to the 15-cm plate. Return the cells to the incubator for 72 h.  crItIcal step For batch retest (see Step 58), use the mixture of individually cloned shRNAs instead of the library, and for a pairwise interaction map (see Step 76) use ligated double-shRNA library.
3| 72 h after transfection, collect the virus by aspiration into a 30-ml Luer-lock syringe (no needle) and then by filtration through a 0.45-µm filter into a 50-ml conical tube.  pause poInt We freshly prepare virus for each infection, although in principle virus can be concentrated, titered and stored at −80 °C for up to 1 year. 9| At the end of the screen, freeze down multiple vials of cells for selected and unselected conditions. As for t0 aliquots, the number of cells in each aliquot should be chosen such that the average representation of shRNAs in each library is 1,000-fold. (e.g., for a library with 20,000 shRNAs, 20 million infected cells should be frozen in each aliquot.) preparation of samples for deep sequencing • tIMInG 3 d 10| Preheat a water bath to 70 °C in preparation for the cell lysis step of DNA extraction using the Qiagen DNA blood maxi kit (see Step 13) .
4|
11|
Thaw the cell aliquots (typically t0, unselected and selected cells) by incubating them in a 37 °C water bath.
12|
Resuspend the cells in 25 ml of PBS into a 50-ml Falcon tube, and pellet them by centrifugation for 5 min at 400g at room temperature.
13|
On the basis of the number of total cells per sample, extract the genomic DNA using the QIAamp DNA blood maxi kit according to the manufacturer's instructions, with the specifications described in the table below. If more than 300 × 10 6 cells are present in the sample, split the cells into >1 Falcon tube before starting. To the manufacturer's instructions, apply the following minor modifications: repeat step 6 (leave first eluate in tube) and pipette up and down to ensure that genomic DNA is in solution; in step 9, spin the mixture for 2 min at 3,800g; in step 10, spin the mixture for 20 min at 3,800g; in the elution step, add 0.8 ml of EB (in the Qiagen kit) per column, incubate it for 5 min and centrifuge it for 5 min at 3,800g.
number of cells <100 × 10 6 <200 × 10 6 <300 × 10 6 Resuspend in PBS 5 ml 10 ml 15 ml
Add Qiagen protease 500 µl 1,000 µl 1,500 µl
Add buffer AL (in Qiagen kit) 6 ml 12 ml 18 ml Add ethanol 5 ml 10 ml 15 ml
Split to how many columns 1 2 3
14| Measure the genomic DNA concentration (typically ~1 mg per 100 × 10 6 cells or more).  pause poInt Eluted genomic DNA can be frozen at −20 °C indefinitely.
15|
Set up a restriction digest of the genomic DNA in a 15-ml Falcon tube. For each 1 mg of genomic DNA, adjust the volume with Qiagen buffer EB to 1,500 µl, mix it with 169 µl of NEB buffer 2 and add 20 µl of PvuII. Incubate the mixture overnight at 37 °C. This digest is appropriate for ~1 mg of genomic DNA, which is the approximate yield from 100 × 10 6 cells per column at Step 13; scale the reaction accordingly for multiple columns.
16| Pour 400 ml of 0.8% (wt/vol) agarose gel in TAE containing 32 µl of 10 mg/ml ethidium bromide into an Owl A1 large gel system using gel combs that create large wells. ! cautIon Ethidium bromide is mutagenic, and it should be handled with care and disposed of properly.
17|
After the gel has solidified, slowly and carefully remove the gel combs. Add TAE to the gel chamber so that the buffer surface is ~1-2 mm below the top surface of the gel.  crItIcal step 1.5-ml wells generated with custom gel combs are very fragile. Tearing of the wells can cause sample leak and cross-contamination of samples.  crItIcal step Large sample volumes cannot be neatly loaded if the gel is under the buffer, so it is necessary to keep the gel surface exposed.
18|
Carefully add the samples in loading buffer to the wells, and run them alongside 2.5 µg of 1 kb+ DNA ladder (in an adjacent small well) at 220 V for ~80 min.
19|
Visualize the PCR products on a low-power UV gel box. Cut a wide gel slice spanning between the 1-kb and 1.6-kb markers ( Fig. 3a) and transfer it to a 50-ml tube. Gel slices are typically ~12 ml in volume.
20|
Add three gel-volumes of Qiagen buffer QG (from the gel extraction kit) to the gel slice, and incubate the slice in a water bath at 55 °C with occasional agitation until the gel is fully dissolved.
21| Add 1/100 of the total buffer QG + gel volume of 3 M sodium acetate (pH 5.2), and mix it.
22|
Purify genomic DNA by collecting the DNA/QG mixture onto Qiagen gel extraction columns (4 columns per 100 × 10 6 cells starting material), using a Qiagen vacuum manifold.  crItIcal step Separate vacuum manifolds should be used for pre-PCR and post-PCR DNA purification to avoid crosscontamination with trace amounts of DNA from other experiments. Great care should be taken to thoroughly wash the manifold with water after each use.
23|
Wash the columns twice with 800 µl of Qiagen buffer PE, and then remove from vacuum manifold and spin the columns for 1 min at 16,000g at room temperature in an Eppendorf centrifuge to dry the membranes.
24|
Elute the DNA from each column with 50 µl of EB, and pool the samples together.
25|
Measure the concentration of post-digest DNA (typically ~30-40 µg per 100 × 10 6 cells).  pause poInt Eluted DNA can be frozen at −20 °C indefinitely.
26|
Use the size-fractionated genomic DNA from Step 25 as a template to PCR-amplify the shRNA-encoding cassette, introducing Illumina adapter sequences with different indexes. For each sample that will be sequenced in the same lane, choose a unique forward primer index from the following set described in supplementary 28| Collect the PCRs from the 96-well plate into a 15-ml conical tube. Once the material has been mixed, only a fraction (typically 800 µl) needs to be processed, and the remaining can be stored as a backup sample. Mix one part of PCR product with four parts of Qiagen buffer PB, and add a 1/100 volume of 3 M sodium acetate (pH 5.2).
29|
Purify the sample/PB mix over a Qiagen PCR purification column, according to the manufacturer's instructions, and elute it in 50 µl of buffer EB.
30|
Load the PCR product in DNA loading buffer onto a 20% (wt/vol) polyacrylamide/TBE gel, distributing 20 µl into adjacent wells of a 12-well gel, and run it for 1 h at 180 V in 0.5× TBE. Once the sample has been mixed, only a fraction of the sample (typically 20%) needs to be loaded onto the gel.
31|
Remove the gel from casing and stain it in 50 ml of 0.5× TBE with 5 µl of 10 mg/ml ethidium bromide for 5 min on a rocking platform at room temperature.
32|
Visualize the PCR products on a low-power UV gel box (Fig. 3b) . The correct products should run at ~250 bp. Excise this band using a razor blade.  crItIcal step For batch retest (see Step 58), the expected size is ~170 bp, and for a double-shRNA library (see Step 76), the expected size is ~190 bp.
? troublesHootInG 33| Combine all slices from a single sample into a D-tube midi electroelution column (pre-soaked in 800 µl of 0.5× TBE for 5 min and emptied), add 800 µl of fresh 0.5× TBE and close.  crItIcal step Make sure that the lid is closed finger-tight.
34|
Electroelute the DNA in TBE for 1.5 h at 160 V; reverse the electrode polarity for the last 2 min of electroelution to ensure that DNA does not stick to the membrane.  crItIcal step Make sure that the tubes stay submerged in TBE throughout the electroelution time.
35|
Collect the electroeluted DNA, mix one part PCR product with four parts Qiagen buffer PB and add a 1/100 volume of 3 M sodium acetate (pH 5.2).
36|
Purify the PCR product on one Qiagen gel extraction column using a vacuum manifold. Wash the column with 1 ml of Qiagen buffer PE and elute it in 100 µl of buffer EB.
37|
Verify the size and concentration of the purified PCR product using procedures recommended by the sequencing facility (such as quantitative PCR (qPCR) or Bioanalyzer), and sequence the on an Illumina HiSeq with primer oMK132. This primer should be added to the primer mix provided by Illumina as follows: for each lane, 240 µl of sequencing mix HP1 (provided with Illumina sequencing reagents) should be mixed with 1.2 µl of 100 µM oMK132. A 1,000-fold representation of library shRNAs by sequencing reads is recommended (e.g., for a library with 50,000 different shRNAs 50 million reads should be obtained).  crItIcal step For batch retest and double-shRNA library (see Steps 58 and 76, respectively), no custom primer is necessary, as the included standard Illumina genomic DNA sequencing primer in HP1 will read the single or paired barcodes.
Data analysis for the primary screen • tIMInG 1-4 d 38|
In the subdirectory growth, create a tab-delimited text file containing, on the first line, the number of doublings untreated WT cells completed during the experiment (calculated in Step 8; parameter 'G'), and, separated by a tab, the difference between that number and the number of doublings treated WT cells completed during the experiment (parameter 'K').
As an example, we have provided the file Example_Primary_GK.txt in the 'growth' subdirectory of the downloadable archive.
39|
Move the sequencing result files, in fasta or Illumina fastq format, to the 'sequencing' subdirectory.
40|
Open a Terminal window and on the command line, change to the directory 'scripts' and enter the IPython console with the following command:
ipython --pylab  crItIcal step The Enthought python distribution enables interactive graphical data display. If you do not want to use this feature, you can execute all scripts directly from the terminal command line by replacing 'run' with 'python' in the following command-line examples (Steps 41-45). In that case, where graphical output is created as part of the program pipeline, the pop-up window with the graph needs to be closed for the program to proceed.
41|
Run the script crop_reads.py to process the sequencing data, with the following command-line arguments: Name of the sequencing data file, e.g., ../sequencing/Sample.fastq; Name of the output file, e.g., ../cropped/Sample.fa; Number of bases after which the sequencing read should be truncated. For the analysis of primary screen samples, 22 is sufficient. Example command line:
In [1] : run crop_reads.py ../sequencing/Sample.fastq ../cropped/Sample.fa 22
42|
Run the script align_primary.py to align the cropped reads to the shRNA library reference with the following commandline arguments: Cropped sequencing data file (e.g., ../cropped/Sample.fa); Prefix for the output files generated by this script, (e.g., Sample); and Name of the primary shRNA library to which the sequencing reads should be aligned (e.g., LibraryName). Note that additional names of other shRNA library names can be specified if the sequenced sample was derived from a cell population transduced with several shRNA libraries. Example command line:
In [2] : run align_primary.py ../cropped/Sample.fa Sample LibraryName 43| Optionally, remove the files in the directories 'cropped' and 'maps' to free up disk space.
44| Repeat Steps 41-43 for all sequenced samples. Typically, these will consist of sets of the t0 sample, a treated sample and an untreated sample. Corresponding example count files, named Example_Primary_t0.counts, Example_Primary_treated. counts and Example_Primary_untreated.counts, respectively, are provided in the 'counts' subdirectory. 
45|
recloning individual shrnas for validation and for genetic interaction mapping • tIMInG 4-5 d 47|
On the basis of the results from the primary screen, choose hit genes to be included in validation experiments and in the genetic interaction map. For each gene, choose the three or four shRNAs that showed the strongest phenotypesideally in two or more independent experimental replicates of the primary screen. Also choose 12 or more negative control shRNAs.
48|
To clone these individual shRNAs into the barcoded vector pMK1200 (ref. 9), first digest 1 µg of plasmid DNA overnight with 1 µl of BstXI according to the enzyme manufacturer's instructions, run the digestion reaction in a 0.8% (wt/vol) agarose gel and extract using a Qiagen gel extraction kit according to the manufacturer's instructions.  crItIcal step Do not dephosphorylate the vector backbone, as the insert will consist of unphosphorylated oligonucleotides.
49|
Order the top and bottom oligonucleotides corresponding to hit shRNA sequences formatted as in the example below for the guide sequence TTTCTTACTCACCCTAAGAACT. The sequences in italics represent unique overhangs that are compatible with BstXI-digested pMK1200; the underlined sequences represent the shRNA loop sequence. Number of different shRNAs in the treated sample: 54252 221 shRNA species found in the untreated sample but not the t0 sample.
121 shRNA species found in the t0 sample but not the untreated sample.
151 shRNA species found in the treated sample but not the t0 sample.
429 shRNA species found in the t0 sample but not the treated sample.
34 shRNA species found in the treated but not the untreated sample.
104 shRNA species found in the untreated but not the treated sample.
The script generates the following output files:
• Example.gammas: Each line summarizes information for one shRNA with the following tab-separated fields: Name of shRNA, growth phenotype in the absence of treatment (gamma), counts in t0 sample and counts in the untreated sample.
• Example.taus:
Each line summarizes information for one shRNA with the following tab-separated fields: Name of shRNA, growth phenotype in the presence of treatment (tau), counts in t0 sample and counts in the treated sample.
• Example.rhos:
Each line summarizes information for one shRNA with the following tab-separated fields: Name of shRNA, phenotype quantifying the resistance to treatment (rho), counts in t0 sample counts in the treated sample.
• Example_pvalues.txt: Each gene on one line with the following tab-separated fields:
• Entrez Gene ID • Official gene symbol • Gene information • Number of shRNAs for which gammas could be calculated • Gene scored as (P)rotective (i.e., shRNAs were enriched) or (S)ensitizing (i.e., shRNAs were depleted) based on gamma phenotype • P value for gene based on gamma phenotype, calculated using the MW U-test • P value for gene based on gamma phenotype, calculated using the KS test • Number of shRNAs for which taus could be calculated • Gene scored as (P)rotective (i.e. shRNAs were enriched) or (S)ensitizing (i.e., shRNAs were depleted) based on tau phenotype • P value for gene based on tau phenotype, calculated using the MW U-test • P value for gene based on tau phenotype, calculated using the KS test • Number of shRNAs for which rhos could be calculated • Gene scored as (P)rotective (i.e., shRNAs were enriched) or (S)ensitizing (i.e., shRNAs were depleted) based on rho phenotype • P value for gene based on rho phenotype, calculated using the MW U-test • P value for gene based on rho phenotype, calculated the using KS test This file is best opened in a program such as Microsoft Excel to allow sorting of genes by P value.
We have previously provided mathematical definitions of the quantitative phenotypes (gamma, tau and rho) and of the approach for calculating P values 9 . 55| Transform 2.5 µl of ligation mixture into DH5α cells and plate onto LB plates containing 100 µg/ml carbenicillin. Incubate the plates at 37 °C overnight, and then prepare DNA using the Qiagen plasmid mini kit.
56|
To validate correct shRNA inserts, sequence clones with primers 5′ pSico-Eco-insert-seq or 3′ pSico-Pci-insert-seq using Sanger sequencing (supplementary table 1 57| After cloning individual barcoded shRNAs as described in Steps 47-56, catalog each in a tab-delimited text file called shRNAs.txt in the subdirectory 'LUT' . An example of such a file is provided in the subdirectory 'LUT' of the downloadable archive. In this file, each line summarizes information for one shRNA in the following tab-separated fields: Name of barcoded shRNA construct, in the following format: EntrezGeneID_GeneSymbol_Number; 5′-to-3′ sequence of top oligo used to clone this shRNA; shRNA name in original pooled library; Name of pooled library; Plasmid number; 5′-to-3′ sequence of upstream barcode; 5′-to-3′ sequence of downstream barcode.
58|
Use the scripts check_upstream_barcode.py and check_downstream_barcode.py to check whether the barcodes (identified by Sanger sequencing in Step 55) are acceptable in terms of their Hamming distance to the barcodes of all other previously accepted shRNA plasmids, and whether they are compatible with restriction enzyme digests at later stages in this protocol. The only command-line argument for check_upstream_barcode.py and check_downstream_barcode.py are the upstream and downstream barcode sequences, respectively, in 5′-to-3′ direction. 
61|
On the command line, change to the directory 'scripts', and enter the IPython console with the following command:
ipython --pylab  crItIcal step The Enthought python distribution enables interactive graphical data display. If you do not want to use this feature, you can execute all scripts directly from the terminal command line by replacing 'run' with 'python' in the following command-line examples (Steps 62-68). In that case, where graphical output is created as part of the program pipeline, the pop-up window with the graph needs to be closed for the program to proceed.
62|
Run the script crop_reads.py to process the sequencing data with the following command-line arguments: Name of the sequencing data file (e.g., ../sequencing/BatchRetestSample.fastq); Name of the output file (e.g., ../cropped/ BatchRetestSample.fa); and Number of bases after which the sequencing read should be truncated. For the analysis of batch retest samples, 16 is sufficient. Example command line:
In [1] : run crop_reads.py ../sequencing/BatchRetestSample.fastq ../cropped/BatchRetestSample.fa 16 63| Run the script align_batch_retest.py to align the cropped reads to the shRNA library reference with the following command-line arguments: Cropped sequencing data file (e.g., ../cropped/BatchRetestSample.fa, and Prefix for the output files generated by this script (e.g., BatchRetestSample). Example command line:
In [2] : run align_batch_retest.py ../cropped/BatchRetestSample.fa BatchRetestSample 64| Optionally, remove the files in the directories 'cropped' and 'maps' to free up disk space.
65|
Repeat Steps 62-64 for all sequenced samples. For batch retests, these may consist of one t0 sample, an untreated sample and several differentially treated samples. For each treatment condition, a file containing the G and K parameters must be created in the subdirectory 'growth', as described for primary screens (Step 38).
66|
To calculate gamma phenotypes, use the script batch_retest_shRNA_gammas.py with the following command-line arguments: Prefix for output files; Counts file for t0 sample; Counts file for untreated sample; File with growth parameters G and K (K is not used by this script); Optional: information on negative controls. If this argument is not provided, the program interprets all shRNA names starting with the prefix '0' as negative controls. Alternatively, custom prefixes can be listed on the command line as consecutive arguments. If no negative control shRNAs are present in the library, the keyword 'all' can be provided to use all shRNAs as an approximation of the null distribution. This option is generally not recommended.
67|
To calculate tau phenotypes, use the script batch_retest_shRNA_taus.py, with the following command-line arguments: Prefix for output files; Counts file for t0 sample; Counts file for treated sample; File with growth parameters G and K.; Optional: information on negative controls. If this argument is not provided, the program interprets all shRNA names starting with the prefix '0' as negative controls. Alternatively, custom prefixes can be listed on the command-line as consecutive arguments. If no negative control shRNAs are present in the library, the keyword 'all' can be provided to use all shRNAs as an approximation of the null distribution. This option is generally not recommended.
68|
To calculate rho phenotypes, use the script batch_retest_shRNA_rhos.py, with the following command-line arguments: Prefix for output files; Counts file for untreated sample; Counts file for treated sample; File with growth parameters G and K.; Optional: information on negative controls. If this argument is not provided, the program interprets all shRNA names starting with the prefix '0' as negative controls. Alternatively, custom prefixes can be listed on the command line as consecutive arguments. If no negative control shRNAs are present in the library, the keyword 'all' can be provided to use all shRNAs as an approximation of the null distribution. This option is generally not recommended. Example command line: 70| Pool the plasmids of the selected shRNAs in equal amounts in one tube. Transfer 1 µg of the pooled shRNAs to two separate tubes; in one tube, set up a restriction digest with KpnI + AvrII to generate a 1,011-bp-long band (insert); in the other tube, set up a restriction digest with KpnI + XbaI to generate a 7,808-bp-long band (backbone).
71|
Run both digests in separate wells on a 0.8% (wt/vol) agarose gel and purify the 1,011-bp-long band (insert) and 7,808-bp-long band (backbone) from the appropriate lane using the Qiagen gel extraction kit according to the manufacturer's instructions.
72|
Ligate, overnight at 16 °C, 1 µg of the 7,808-bp-long fragment to 388 ng of the 1,011-bp-long fragment in a total reaction volume of 10 µl, using 1 µl of T4 DNA ligase (2,000 U) and 1 µl of 10× T4 DNA ligase buffer.
73| Transform 5 µl of this mixture into MegaX bacterial cells by electroporation in a 1-mm-gap cuvette at 2 kV, 200 ohms and 25 µF, and recover it in 11 ml of SOC medium in an Erlenmeyer flask for 1 h at 37 °C while shaking at 250 r.p.m.
74|
Plate the bacteria on sufficient numbers of Qtray agar plates to get 1,000 colonies per library shRNA. Typically, 500 µl plated from
Step 72 yields ~100,000 colonies per plate. Incubate the plates overnight at 37 °C.
75|
The next day, scrape the colonies from the plate using 20 ml of LB per plate and a glass rod.
76|
Pool the LB from all plates and use it to prepare library DNA using the Qiagen gigaprep kit; the typical yield is ~10 mg. 
79|
Move the sequencing results files, in fasta or Illumina fastq format, to the 'sequencing' subdirectory.
80|
On the command line, change to the 'scripts' directory, and enter the IPython console with the following command:
ipython --pylab  crItIcal step The Enthought python distribution enables interactive graphical data display. If you do not want to use this feature, you can execute all scripts directly from the terminal command line by replacing 'run' with 'python' in the following command-line examples (Steps 81-93). In that case, where graphical output is created as part of the program pipeline, the pop-up window with the graph needs to be closed for the program to proceed.
81|
Run the script crop_reads.py to process the sequencing data with the following command-line arguments: Name of the sequencing data file (e.g., ../sequencing/DoubleshRNASample.fastq); Name of the output file (e.g., ../cropped/ DoubleshRNASample.fa); and Number of bases after which the sequencing read should be truncated. For the analysis of double-shRNA samples, 26 is sufficient.
Example command line:
In [1] : run crop_reads.py ../sequencing/DoubleshRNASample.fastq ../cropped/ DoubleshRNASample.fa 26
82|
Run the script align_double_shRNAs.py to align the cropped reads to the shRNA library reference with the following command-line arguments: Cropped sequencing data file (e.g., ../cropped/DoubleshRNASample.fa); and Prefix for the output files generated by this script (e.g., DoubleshRNASample).
Example command line:
In [2] : run align_double_shRNAs.py ../cropped/DoubleshRNASample.fa DoubleshRNASample 83| Optionally, remove files in the directory 'cropped' to free up disk space.
84|
Repeat Steps 81-83 for all sequenced samples. For double-shRNA screens, these typically consist of one t0 sample, a treated sample and an untreated sample. Two replicates of the screen should typically be carried out. The following example count files are provided in the subdirectory counts: Rep1_t0.counts, Rep1_treated.counts, Rep1_untreated.counts, Rep2_t0.counts, Rep2_treated.counts and Rep2_untreated.counts.
85|
For each treatment condition, create a file containing the G and K parameters in the 'growth' subdirectory, as described for primary screens (Step 38). Example files Rep1_GK.txt and Rep2_GK.txt are provided in the 'growth' sudirectory or the downloadable archive.
86|
Call the script double_shRNA_phenotypes.py with only one command-line argument, the prefix for the output files (e.g., .
./results/Rep1). Supply further information via an interactive dialog in the terminal window, as exemplified below:
In [ The script generates several graphs ( Fig. 6; supplementary Figs. 3 and 4) that are further explained in the ANTICIPATED RESULTS section.
? troublesHootInG 87| Calculate genetic interactions using the script calculate_GIs.py. The only command-line argument is the same Prefix entered for the previous script (e.g., .
./results/Rep1). In an interactive dialog, the phenotypes for which genetic interactions should be calculated are specified. 
88|
To inspect individual genes of interest for how well different definitions of genetic interactions describe the raw data, use interactive functions described in box 2 to generate graphs (illustrated in Fig. 7 and supplementary Fig. 6 ).
89|
If none of the definitions of genetic interactions we described previously 9 are a good fit for a given experiment (see ANTICIPATED RESULTS and box 2), users should implement their own custom definitions by editing the script calculate_GIs.py.
90|
Repeat Steps 86-89 for the second replicate of the screen. The script generates several output files that tabulate genetic interactions averaged between the two replicates. Different methods for calculating genetic interactions are indicated by the following code, which appears in the corresponding file names: 'PhenotypeExpectedFlip' . 'Phenotype' can be rho, gamma or tau. 'Expected' can be p (for product definition of expected double-shRNA phenotypes), s (for sum definition of expected double-shRNA phenotypes), or f (for empirical fit definition of expected double-shRNA phenotypes). The code for 'Flip' can be absent for raw genetic interactions, flip1 for Definition 1 of buffering/synergistic genetic interactions or flip2 for Definition 2 of buffering/synergistic genetic interactions. We have previously defined these different methods to calculate genetic interactions quantitatively 9 . For example, the above command line will create, among others, the following output file: ../results/Rep1Rep2_Rhofflip2GI.txt. The script also generates several graphs as pop-up windows, as described in the ANTICIPATED RESULTS section.
92|
On the basis of the results produced by the scripts calculate_GIs.py and compare_GIs.py, decide which definition of genetic interactions (as defined in
Step 91, e.g., Rhof) is most appropriate for the data. Criteria for this decision are as follows: first, for a given shRNA, most double shRNAs should show the expected double-shRNA phenotype according to the chosen definition. For example, supplementary Figure 5a reveals that the sum and product definitions are not adequate for most genes in the example data set; therefore, the empirical fit for individual shRNAs should be selected here. Second, genetic interaction patterns for shRNAs targeting the same gene should on average be more correlated than genetic interaction patterns for other shRNAs (supplementary Fig. 7 ).
93|
Use the script filter_GIs.py to remove shRNAs with possible off-target effects from the data set. Such shRNAs are detected as shRNAs whose genetic interaction pattern is not sufficiently correlated with that of other shRNAs targeting the same gene 9 . The script requires two command-line arguments: Genetic interaction file to be used as input (e.g., ../results/ Rep1Rep2_RhofGI.txt). Cutoff for required correlation of genetic interaction pattern with that of other shRNAs targeting the same gene, expressed in standard deviations of the distribution of correlation coefficients between genetic interaction patterns of a given shRNA and all other shRNAs in the data set (e.g., 0.8) Example command line:
In [9] : run filter_GIs.py ../results/Rep1Rep2_RhofGI 0.8
The script lists the shRNAs that were removed from the data set as screen output, for example:
94| Open Cluster 3.0 (ref. 27 ) and load the gene-based genetic interaction file generated by the script filter_GIs.py (e.g., ../results/Rep1Rep2_KfGI_minZ0.8_GeneGI.txt). Apply Hierarchical clustering on both 'Genes' and 'Arrays' using Uncentered Correlation as a similarity metric and Average Linkage as the clustering method. This will generate three files with the same prefix and the extensions .atr, .cdt and .gtr.
Box 2 | Graphical exploration of double-shRNA phenotypes
• rho_sd(), gamma_sd(). Comparison of single shRNA phenotypes (derived from double-shRNAs containing one negative control shRNAs) and double-shRNA phenotypes, in combination with one shRNA of interest. These functions accept the following arguments:
• Name of an shRNA of interest, in quotes. E.g. 'SEC23B_4' .
• In [5] : rho_sd('SEC23B_4', LabelAboveZ=2.5,Link=True)
• -gene_rho_sd(), gene_gamma_sd(). Similar to the previous function, except that data from shRNAs targeting the same gene are averaged. This typically vastly reduces the noise. These functions accept the following arguments:
• Gene of interest, in quotes. E.g. 'SEC23B' .
• Optional: LabelAboveZ (floating point number): Display names of genes if their average genetic interaction with the gene of interest is this many standard deviations above the mean. Default is 100, which typically suppresses all shRNA labels In [6] : gene_rho_sd('SEC23B', LabelAboveZ=1.5, Link=True, PlotSD=True)
• ab_rho_sd_yellow_blue() and ab_gamma_sd_yellow_blue(). Similar to rho_sd() and gamma_sd(), but data for each shRNA are averaged for the shRNA occurring in the first and in the second position within the double-shRNA. These functions accept the following arguments:
• Name of an shRNA of interest, in quotes (e.g., 'SEC23B_4').
• Optional: ShowLabels (Boolean):
• True: Display shRNA names.
• False (default): Do not display shRNA names. For example, the following command generates the graph shown in Figure 7 :
In [7] : ab_rho_sd_yellow_blue('SEC23B_4',ShowLabels=True) 95| Open Java TreeView 27 and load the .cdt file generated by Cluster 3.0 (e.g., ../results/Rep1Rep2_KfGI_minZ0.8_ GeneGI.txt.cdt) for interactive exploration of the genetic interaction map. Refer to the Java TreeView documentation (http://jtreeview.sourceforge.net/manual.html) for instructions.
? troublesHootInG Troubleshooting advice can be found in table 2. Unexpected bands are observed
Primer-dimers and other template-independent products are present Perform and load a negative control reaction lacking template on the gel next to the sample of interest. Run the gel long enough to separate unwanted bands from the band of interest. Cut out only the desired band in
Step 32 (Fig. 3b) 0 (continued)
antIcIpateD results
The results of the primary screen depend strongly on the biological question. In some cases, a single gene is detected as an exceptionally strong hit 28 . In other cases, dozens or hundreds of hit genes are detected 10 . In the latter case, a genetic interaction map is likely to generate hypotheses for functional connections between genes, such as physical interaction or enzyme-substrate relationships (Fig. 8) . These can then be tested using classical cell biological and biochemical approaches.
The following sections describe in more detail the anticipated results of the individual steps of the bioinformatics analysis.
analysis of the primary screen
The script analyze_primary_screen.py (Step 45) will generate the following graphical output:
Scatter plots comparing shRNA frequencies in pairs of samples (e.g., Fig. 4a) . If the negative controls show a significantly broader deviation from the diagonal than in this example, this can be indicative of bottlenecks during the screen or sample preparation that caused Poisson (sampling) noise. Histograms of the number of shRNA phenotypes obtained for each gene (e.g., supplementary Fig. 1a) . If the number of shRNAs per gene is much lower for a subset of genes, this can indicate that knockdown of these genes was toxic to cells. P values for these genes need to be interpreted with caution.
Comparison of the phenotypes of all shRNAs, compared with negative control shRNAs (either as cumulative curves, e.g., supplementary Fig. 1b, or histograms, Fig. 4b) . Generally, the phenotype distribution for negative control shRNAs Figure 4 At least one of the cell populations underwent a bottleneck during the screen or sample preparation
Repeat or re-design the screening protocol (Step 7) to avoid population bottlenecks shRNA phenotypes show a bimodal distribution or have a very broad 'shoulder' on one side of the distribution
In at least one of the cell populations, bias was introduced during the sample preparation Make sure to use the same number of PCR cycles in Step 27 for all samples that will be compared computationally
If the primary shRNA library contains shRNAs of different lengths (e.g., 21 mers and 22 mers), it is important to avoid introducing size bias when cutting bands from the polyacrylamide gels (Step 32) . Therefore, the band should be cut out very generously, leaving a margin of unstained gel around the band . 2a) . If the results from the MW and KS tests are divergent, the data set may be very noisy owing to bottlenecks during screening or sample preparation, and P values need to be interpreted with care. In particular, noisy phenotypes can easily score a significant KS P value by chance, so MW P values are more trustworthy for noisy data sets 9 .
Scatter plot comparing gene P values based on growth in the absence of treatment (gamma) with P values based on growth in the presence of treatment (tau; Fig. 5a ). Genes that have major effects on the response to treatment, but not on growth in the absence of treatment, will lie close to the y axis.
These graphs are saved as graphics file with the prefix specified on the command line. They can also be explored interactively, e.g., by zooming into areas of the P value scatter plots. By using the commands gene_gamma(), gene_tau(), gene_rho() ( Step 46), data for individual shRNAs for a given gene are visualized (Fig. 5b) .
analysis of the batch retest
The scripts batch_retest_shRNA_gammas.py (Step 66), batch_retest_shRNA_taus.py (Step 67) and batch_retest_shRNA_rhos. py ( Step 68) create the output files Prefix.gammas, Prefix.taus and Prefix.rhos, respectively, in the same format as the corresponding files generated by analyze_primary_screen.py. The shRNA phenotypes should be similar to those obtained in the primary screen, but as the batch retest is usually carried out at a higher representation phenotypes are quantified more accurately in the batch retest. The scripts in Steps 66-68 also generate several graphs corresponding to those generated by analyze_primary_screen.py (see above).
analysis of the double-shrna screen
The script align_double_shRNAs.py (Step 82) creates several graphs that analyze the phenotypes of pairs of shRNAs, A and B, in the AB and the BA orientations. AB and BA phenotypes should be very similar; large differences between AB and BA are therefore mostly reflective of experimental noise. The distribution of AB-BA differences in the entire data set is visualized by a histogram (e.g., supplementary Fig. 3a) . 2D histograms (based on hexagonally binned heat maps) explore the dependence of noise on phenotypic strength (supplementary Fig. 3b ) and abundance of double shRNAs at time t0 (Fig. 6) . Less abundant double-shRNAs typically give noisier phenotypes, indicating that data quality can be further improved by scaling up the cell population for the pooled screen. A further internal quality control is the comparison of phenotypes of double-shRNAs containing one shRNA targeting a hit gene and one negative control shRNA in the two possible orientations (supplementary Fig. 4) . A small systematic deviation is observed, as shRNAs in the second position of the double-shRNAs are slightly more effective. The script calculate_GIs.py (Step 87) generates the following graphs:
Comparison of different definitions for the expected double-mutant phenotype. In cases where neither the sum nor product definitions provide a good 'fit' of the actual data, the empirical-fit definition should be chosen (supplementary Fig. 5a ).
Comparison of slopes for empirical linear fits for shRNAs obtained either along 'rows' or 'columns' of the double-shRNA phenotype table-both should be identical. This graph can reveal noise or systematic biases (supplementary Fig. 5b) .
The script compare_GIs.py (Step 91) generates the following graphical output: 2D histograms (based on hexagonally binned heat maps) visualize the correlation of genetic interactions between shRNA pairs across the two replicates (e.g., supplementary Fig. 7a ).
• In the version of this article initially published, a sentence in Step 49 read "Order the top and bottom oligonucleotides corresponding to hit shRNA sequences formatted as in the example below for the target site TTTCTTACTCACCCTAAGAACT". The sentence has been corrected to replace 'target site' with 'guide sequence' . The error has been corrected in the HTML and PDF versions of the article.
